Verastem, Inc.
For the period ended Jun 30, 2025. Filed Aug 7, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 7, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
Securities Trading Plans of Directors and Executive Officers
On June 10, 2025, Paul Bunn, Ph.D., amember of the board of directors, adopted a Rule 10b5-1 plan providing for the sale of up to 20,833 shares of the Company’s common stock. Pursuant to this plan, Dr. Bunn may sell shares of common stock beginning on October 9, 2025, subject to the terms of the plan, and the plan will terminate on or prior to October 8, 2026. The trading plan is intended to satisfy the affirmative defense of Rule 10b5-1(c).
On June 11, 2025, Michael Kauffman, Ph.D., thechairman of the board of directors, adopted a Rule 10b5-1 plan providing for the sale of up to 42,336 shares of the Company’s common stock. Pursuant to this plan, Dr. Kauffman may sell shares of common stock beginning on October 10, 2025, subject to the terms of the plan, and the plan will terminate on or prior to October 9, 2026. The trading plan is intended to satisfy the affirmative defense of Rule 10b5-1(c).
On June 18, 2025, Daniel Paterson, thechief executive officer and a member of the board of directors, adopted a Rule 10b5-1 plan providing for the sale of up to 31,970 shares of the Company’s common stock. Pursuant to this plan, Dr. Paterson may sell shares of common stock beginning on September 17, 2025, subject to the terms of the plan, and the plan will terminate on or prior to September 17, 2026. The trading plan is intended to satisfy the affirmative defense of Rule 10b5-1(c).
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.